ATLAS: Next Generation Treatment for Intracranial Aneurysms
Safety and Effectiveness of the Treatment of Wide-Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System.
NANO: Effectiveness and Safety of Small Aneurysm Coiling Trial
NANO: Effectiveness and Safety of Small Aneurysm Coiling Trial
This is a prospective study to compare the safety and efficacy of treating small aneurysms with coils specially designed for small aneurysms to historically reported rates of safety and efficacy for the treatment of larger aneurysms.
If you would like to explore more clinical information about this trial, please see the trial page on ClinicalTrials.gov
You Might Also Enjoy...
COMPASS Trial: A Direct Aspiration First Pass Technique
Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours.
StrokeNet: Developed by the National Institute of Health
StrokeNet, developed by NIH, is the new structure for federal funding of all aspects of stroke research including prevention, acute treatment, and recovery / rehabilitation.
We Are Committed to Clinical Research
RIA has a rich history of participation in clinical research and innovation dating back to the 1980s. Many of our physicians believe it is important to contribute to science and advance medicine.
Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device
The full name of this study is: Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms.
Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil (SMART)
This is a prospective, multi-center study of patients treated in accordance with the cleared indications for the Penumbra SMART CoilTM System (SMART), Penumbra Coil 400TM (PC 400), and Penumbra Occlusion DeviceTM (POD).